Search results :

Carboplatin

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: L01XA02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8
Nausea 15% - 92% x x x x x x x x
Anaemia 71% - 90% x x x x x x x x
Leukopenia 85% x x x x x x x x
Vomiting 53% - 92% x x x x x x x x
Neutropenia 67% x x x
Thrombocytopenia 62% x x x x x x x x
Hyponatraemia 29% x x x
Hypomagnesaemia 29% x x x
Phosphatase alkaline increased 24% x
Pain 23% x x x x x x x
Hypocalcaemia 22% x x x
Hypokalaemia 20% x x x
Abdominal pain 17% x
Hypersensitivity 2-30% x x x x x x x x
Aspartate aminotransferase increased 15% x
Blood urea increased 14% x
Asthenia 8% - 11% x x x x x x x x
Diarrhoea 6% x x x x x x x x
Neuropathy peripheral 4% - 6% x x x x x x x
Serum creatinine increased 6% x
Infection 4% - 5% x x x x x x
Haemorrhage 5% x x x x x
Neurotoxicity 5% x x x x
Blood bilirubin increased 5% x
Constipation 3% - 6% x x x x x x x x
Alopecia 2% - 3% x x x x x x x x
Tinnitus 1% x x x
Ototoxicity 1% x x x x x x x x
Mucosal inflammation 1% x x x x x x
Influenza-like symptoms 1% x
Dysgeusia 1% x
Angina pectoris x x
Anorexia x x x x x
Arthralgia x x
Bronchospasm x x
Neoplasm malignant x x x x x
Connective tissue disorder x x
Dehydration x x x x
Dermatitis exfoliative x x
Diuresis x x x x x x
Dyspnoea x
Embolism x x x x x
Palmar erythema x
Rash x
Extravasation x x x x x x
Eye disorder x
Fatigue x
Body temperature increased x x x x x x x x
Cardiac arrest x x
Cardiac disorder x x
Cardiac failure x x x x x x x
Haemolytic uraemic syndrome x x x x x x x x
Hypertension x x x x x x
Hypotension x x x
Renal failure acute x x x
Leukaemia x x
Myelodysplastic syndrome x x
Myocardial infarction x x
Necrosis x x x x x
Paraesthesia x x x x x x x x
Pruritus x x x
Stomatitis x x x x
Cerebrovascular accident x x x x x
Swelling x x x x x x
Tachycardia x
Urticaria x x
Angiopathy x x
Wheezing x
Chills x
Peripheral sensory neuropathy x
Injection site reaction x x x x x
Myocardial ischaemia x x
Kidney function abnormal x x x x x
Liver function test abnormal x x x x x
Bone marrow depression x x x x x
Blindness cortical x x
Malnutrition x x
Unspecified disorder of skin and subcutaneous tissue x x
Malaise x x x x x
Myalgia x x
Rash erythematous x x
Neurological symptom x x x x x
Hepatotoxicity x
Renal function test abnormal x x x x x
Creatinine low x
Redness x x x x x
Anaphylactoid reaction x x x
Vision blurred x
Nausea alone x x x x x
Rigors x
Visual disturbance x x x x x x x
Nephrotoxicity x x x x x x x x
Drug interaction x
Gastrointestinal pain x
Tendon reflex decreased x x
Febrile neutropenia x
Ischaemic coronary artery disorders x x
Myelosuppression x x x
Gastrointestinal toxicity x x x x x
Perioral tingling x
Hearing impaired x x
Gastrointestinal tract irritation x
Unspecified visual loss x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

CARBOPLATIN

Side effects:42
Source:FDA Structured Product Label

CARBOPLATIN

Side effects:43
Source:FDA Structured Product Label

CARBOPLATIN

Side effects:44
Source:FDA Structured Product Label

carboplatin

Side effects:45
Source:FDA Structured Product Label

CARBOPLATIN

Side effects:45
Source:FDA Structured Product Label

Carboplatin

Side effects:50
Source:BC Cancer

Carboplatin / CARBOPLATIN INJECTION

Side effects:51
Source:medicines.org.au

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label